Rallybio Corp — Form 8-K
Filed November 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Rallybio filed an 8-K on November 4, 2026, disclosing Item 5.02 (director/officer changes and compensatory arrangements), Item 5.07 (shareholder vote submission), and Item 8.01 (other events). The filing header indicates these matters were submitted but the specific details—names of departing directors, officers affected, compensation amounts, vote results, and nature of other events—are not provided in the accessible text excerpts.
Why this rating
Without concrete details on who departed, compensation changes, or vote outcomes, cannot assess materiality. For $10.6M company, officer changes could be significant if C-level; routine if mid-level. Placeholder 8-K structure suggests administrative reporting rather than transformational event.
Extracted items
- 5.02 exec change
- 5.07 shareholder vote
- 8.01 other event
- 9.01 exhibits
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.